Domains of SF-36 | Intervention Group, n = 35 | Control Group, n = 35 | p Intergroup** | ||||||
---|---|---|---|---|---|---|---|---|---|
T0 | T6 | T12 | T24 | T0 | T6 | T12 | T24 | ||
Bodily pain | 58.5 (26.3) | 62.7 (21.0) | 65.0 (22.6) | 60.8 (19.2) | 54.4 (23.2) | 61.5 (22.6) | 60.3 (22.5) | 57.9 (23.1) | 0.479 |
General health | 56.4 (23.7) | 54.0 (24.2) | 56.6 (23.1) | 54.3 (24.1) | 42.3 (21.4) | 6.9 (21.3) | 46.9 (22.9) | 47.2 (23.2) | 0.056 |
Mental health | 64.2 (25.5) | 68.1 (24.0) | 71.1 (21.6) | 69.5 (22.7) | 65.9 (22.0) | 67.2 (25.0) | 66.3 (22.0) | 69.7 (21.1) | 0.843 |
Physical functioning | 60.7 (20.8) | 61.0 (24.5) | 66.3 (19.8)* | 66.4 (20.9) | 57.9 (20.4) | 58.0 (18.4) | 62.4 (20.8)* | 58.7 (24.3) | 0.340 |
Role emotional | 57.0 (42.5) | 59.9 (42.6) | 58.0 (46.0) | 58.0 (44.6) | 54.2 (46.5) | 51.3 (43.8) | 54.1 (40.5) | 52.3 (45.9) | 0.541 |
Role physical | 53.6 (42.5) | 54.3 (40.4) | 57.9 (42.8) | 56.4 (43.4) | 45.0 (44.5) | 41.4 (38.8) | 47.9 (40.8) | 43.6 (44.7) | 0.177 |
Social aspects | 72.3 (28.2) | 73.0 (24.0) | 74.1 (24.4) | 71.9 (28.3) | 60.9 (25.9) | 69.4 (25.8) | 66.6 (26.8) | 67.3 (24.0) | 0.199 |
Vitality | 60.6 (23.8) | 61.3 (23.0) | 62.7 (24.1) | 63.3 (24.0) | 56.0 (20.8) | 57.6 (18.4) | 59.6 (21.7) | 57.7 (22.1) | 0.364 |
↵* p < 0.05 compared with T6.
↵** ANOVA test.
SF-36: Medical Outcomes Study Short Form-36; T0: baseline assessment before randomization; T6: assessment 6 weeks after the start of the program; T12: assessment 12 weeks after the start of the program; T24: assessment 24 weeks after the start of the program.